Ranbaxy Laboratories has moved higher by 7% to Rs 412 on back of heavy volumes on the bourses. The stock opened at Rs 388 and hit a high of Rs 414, its highest level since June this year, on the National Stock Exchange (NSE).
A combined 6.45 million shares have changed hands on the counter till late noon deals against an average sub 7 million shares that were traded daily in past two weeks on NSE and BSE.
The stock of pharmaceutical company has rallied 23% in past three days, after falling about 13%, it’s sharpest single day fall since May 2009, on Wednesday.
According to Business Standard reports, the drug maker had identified select therapeutic areas and regions, which would drive its future growth.
According to Ranbaxy, the new strategy aims to attain leadership through monetisation of its generic filings, differentiated product strategy, cost optimisation, improvement in productivity, effective use of distribution network and superior manufacturing capability, added report.
A combined 6.45 million shares have changed hands on the counter till late noon deals against an average sub 7 million shares that were traded daily in past two weeks on NSE and BSE.
The stock of pharmaceutical company has rallied 23% in past three days, after falling about 13%, it’s sharpest single day fall since May 2009, on Wednesday.
According to Business Standard reports, the drug maker had identified select therapeutic areas and regions, which would drive its future growth.
According to Ranbaxy, the new strategy aims to attain leadership through monetisation of its generic filings, differentiated product strategy, cost optimisation, improvement in productivity, effective use of distribution network and superior manufacturing capability, added report.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%